LPL Financial
MACK

LPL Financial’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

LPL Financial’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,283
Closed -$32K – 2982
2017
Q2 		$32K Sell
3,283
-133
-4% -$2.72K ﹤0.01% 2762
2017
Q1 		$86K Buy
3,416
+98
+3% +$2.45K ﹤0.01% 2629
2016
Q4 		$104K Sell
3,318
-203
-6% -$8.66K ﹤0.01% 2591
2016
Q3 		$165K Buy
3,521
+203
+6% +$8.43K ﹤0.01% 2449
2016
Q2 		$149K Sell
3,318
-2,682
-45% -$146K ﹤0.01% 2444
2016
Q1 		$391K Buy
6,000
+509
+9% +$26.6K ﹤0.01% 2330
2015
Q4 		$338K Buy
5,491
+2,415
+79% +$170K ﹤0.01% 2458
2015
Q3 		$231K Buy
3,076
+295
+11% +$24.1K ﹤0.01% 2412
2015
Q2 		$268K Buy
2,781
+515
+23% +$49K ﹤0.01% 2403
2015
Q1 		$215K Buy
2,266
+240
+12% +$20.4K ﹤0.01% 2503
2014
Q4 		$180K Sell
2,026
-395
-16% -$28.8K ﹤0.01% 2531
2014
Q3 		$161K Sell
2,421
-29
-1% -$1.55K ﹤0.01% 2526
2014
Q2 		$141K Sell
2,450
-938
-28% -$47.6K ﹤0.01% 2564
2014
Q1 		$134K Buy
3,388
+413
+14% +$17.7K ﹤0.01% 2529
2013
Q4 		$125K Buy
2,975
+222
+8% +$6.44K ﹤0.01% 2537
2013
Q3 		$75K Sell
2,753
-131
-5% -$4.58K ﹤0.01% 2472
2013
Q2 		$153K Buy
+2,884
New +$126K ﹤0.01% 2274

Other funds holding MACK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

LPL Financial's MACK Position: Q3 2017 in Review

LPL Financial sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q3 2017, closing a stake of 3,283 shares — an estimated $32K sold.

LPL Financial first reported a position in MACK in Q2 2013 and held it in 17 quarters. The position peaked at $391K in Q1 2016. 73 funds tracked by Wall St. Rank hold MACK as of Q3 2017.

  • LPL Financial reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
  • LPL Financial sold 3,283 Merrimack Pharmaceuticals, Inc. shares in Q3 2017, an estimated $32K.
  • LPL Financial first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2013 and held it in 17 quarters.
  • LPL Financial's Merrimack Pharmaceuticals, Inc. position peaked at $391K in Q1 2016.
  • 73 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q3 2017.

Based on LPL Financial's 13F filing for Q3 2017, filed 14 Nov 2017.